Columbia Basin Bioscience Makes Significant Investment in CBD Quality, Anticipating Industry Regulation and Scrutiny

Columbia Basin Bioscience Makes Significant Investment in CBD Quality, Anticipating Industry Regulation and Scrutiny

HERMISTON, Ore., Jan. 16, 2020 /PRNewswire/ — Columbia Basin Bioscience designed and built its sole-source, closed loop industrial hemp operation fully expecting the U.S. Food and Drug Administration to begin regulating cannabidiol producers and products. The fast-growing CBD industry has attracted a wide variety of operators who bring a mix of passion, skill and expertise to the field in an effort to find a business and manufacturing model that works. The result of the industry’s experimental approach, however, has been CBD products of varying degrees of quality ­– and consumer confusion. As a consequence, the U.S. Department of Agriculture implemented regulatory guardrails in October 2019. Columbia Basin Bioscience (CBB) expects the FDA to follow suit, providing CBD producers with specific quality and content standards and strict manufacturing practices. With the goals of producing high quality, high purity CBD distillate oil and isolate that will meet or surpass eventual regulation, CBB made significant investment in its industrial hemp farm and processing facility that started operations in late 2019. CBB has millions of pounds of hemp farmed under the care of CEO and third-generation farmer Alan Cleaver and his team on their 2000+ acres of land in Oregon. It is carefully harvested, dried on site in the world’s largest, purpose-built hemp dryer…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Columbia Basin Bioscience Makes Significant Investment in CBD Quality, Anticipating Industry Regulation and Scrutiny
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.